Nisha Sharma

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)

Sarah E. Pinder, Abeer M. Shaaban, Rahul Deb et al. · Clinical Radiology · 2018 · 187 citations

Medicine, Oncology, Pathology +16

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Rajiv Dave, Baek Kim, Alona Courtney et al. · British Journal of Cancer · 2021 · 92 citations · Full text

Medicine, Oncology, Surgery +9

British Society of Breast Radiology Annual Scientific Meeting 2016

Ameerah Mohd Azmil, Gaurav Jyoti Bansal, Eleri Davies et al. · Breast Cancer Research · 2016 · 86 citations · Full text

Medicine, Biostatistics, Radiology +17

European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO

Isabel T. Rubio, Lynda Wyld, Lorenza Marotti et al. · European Journal of Surgical Oncology · 2023 · 81 citations · Full text

Medicine, Oncology, Surgery +14